Hospital Variation in Intensive Care Resource Utilization and Mortality in Newly Diagnosed Pediatric Leukemia
- PMID: 29528977
- PMCID: PMC5986594
- DOI: 10.1097/PCC.0000000000001525
Hospital Variation in Intensive Care Resource Utilization and Mortality in Newly Diagnosed Pediatric Leukemia
Abstract
Objectives: To evaluate hospital-level variability in resource utilization and mortality in children with new leukemia who require ICU support, and identify factors associated with variation.
Design: Retrospective cohort study.
Setting: Children's hospitals contributing to the Pediatric Health Information Systems administrative database from 1999 to 2011.
Patients: Inpatients less than 25 years old with newly diagnosed acute lymphocytic leukemia or acute myeloid leukemia requiring ICU support (n = 1,754).
Interventions, measurements, and main results: Evaluated exposures included leukemia type, year of diagnosis, and hospital-wide proportion of patients with public insurance. The main outcome was hospital mortality. Wide variability existed in the ICU resources used across hospitals. Combined acute lymphocytic leukemia and acute myeloid leukemia mortality varied by hospital from 0% (95% CI, 0-14.8%) to 42.9% (95% CI, 17.7-71.1%). A mixed-effects model with a hospital-level random effect suggests significant variation across hospitals in mortality (p = 0.007). When including patient and hospital factors as fixed effects into the model, younger age, acute myeloid leukemia versus acute lymphocytic leukemia diagnosis, leukemia diagnosis prior to 2005, hospital-wide proportion of public insurance patients, and hospital-level proportion of leukemia patients receiving ICU care are significantly associated with mortality. The variation across hospitals remains significant with all patient factors included (p = 0.021) but is no longer significant after adjusting for the hospital-level factors proportion of public insurance and proportion receiving ICU care (p = 0.48).
Conclusions: Wide hospital-level variability in ICU resource utilization and mortality exists in the care of children with leukemia requiring ICU support. Hospital payer mix is associated with some mortality variability. Additional study into how ICU support could be standardized through clinical practice guidelines, impact of payer mix on hospital resources allocation to the ICU, and subsequent impact on patient outcomes is warranted.
Conflict of interest statement
Figures



Comment in
-
Are We the Best We Can Be?Pediatr Crit Care Med. 2018 Jun;19(6):592-593. doi: 10.1097/PCC.0000000000001542. Pediatr Crit Care Med. 2018. PMID: 29863648 No abstract available.
Similar articles
-
Auditing Practice Style Variation in Pediatric Inpatient Asthma Care.JAMA Pediatr. 2016 Sep 1;170(9):878-86. doi: 10.1001/jamapediatrics.2016.0911. JAMA Pediatr. 2016. PMID: 27398908
-
Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States.Pediatr Crit Care Med. 2014 Feb;15(2):112-20. doi: 10.1097/PCC.0000000000000042. Pediatr Crit Care Med. 2014. PMID: 24366507 Free PMC article.
-
Postoperative utilization of critical care services by cardiac surgery: a multicenter study in the Canadian healthcare system.Crit Care Med. 1993 Jun;21(6):851-9. doi: 10.1097/00003246-199306000-00012. Crit Care Med. 1993. PMID: 8504652
-
Utilization of ICU Rehabilitation Services in Pediatric Patients With a Prolonged ICU Stay.Crit Care Med. 2021 Sep 1;49(9):e812-e821. doi: 10.1097/CCM.0000000000005036. Crit Care Med. 2021. PMID: 33870920
-
Variability in Antibiotic Use Across PICUs.Pediatr Crit Care Med. 2018 Jun;19(6):519-527. doi: 10.1097/PCC.0000000000001535. Pediatr Crit Care Med. 2018. PMID: 29533352
Cited by
-
Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials.Pediatr Blood Cancer. 2024 Oct;71(10):e31192. doi: 10.1002/pbc.31192. Epub 2024 Jul 12. Pediatr Blood Cancer. 2024. PMID: 38997807
-
Leveraging machine learning to identify acute myeloid leukemia patients and their chemotherapy regimens in an administrative database.Pediatr Blood Cancer. 2023 May;70(5):e30260. doi: 10.1002/pbc.30260. Epub 2023 Feb 23. Pediatr Blood Cancer. 2023. PMID: 36815580 Free PMC article.
-
The epidemiology of pediatric oncology and hematopoietic cell transplant admissions to U.S. intensive care units from 2001-2019.Front Oncol. 2024 Dec 3;14:1501977. doi: 10.3389/fonc.2024.1501977. eCollection 2024. Front Oncol. 2024. PMID: 39697227 Free PMC article.
References
-
- Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2011. Bethesda, MD: Apr, 2014. based on November 2013 SEER data submission, posted to the SEER web site.
-
- Ward E, DeSantis C, Robbins A, et al. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103. - PubMed
-
- Unguru Y. The successful integration of research and care: how pediatric oncology became the subspecialty in which research defines the standard of care. Pediatr Blood Cancer. 2011;56(7):1019–1025. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical